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or patients with chronic liver disease and liver cirrhosis, portal hypertension is an important management target. Advanced portal hypertension causes portosystemic shunts, and esophageal varices are a life-threatening complication in decompensated liver cirrhosis. Although measurement of the hepatic venous pressure gradient is the reference standard for evaluating portal hypertension, the application of the hepatic venous pressure gradient is limited for routine monitoring of portal hypertension because of its invasiveness and low availability. Hence, parameters such as the platelet count-tospleen diameter ratio and Model for End-Stage Liver Disease (MELD) score have been used as noninvasive monitoring methods. Sonoelastography of the liver and spleen has been studied as an alternative modality for predicting portal hypertension and esophageal varices. 1 Previous studies using transient elastography have suggested that spleen stiffness has high diagnostic accuracy in predicting portal hypertension and esophageal varices because spleen stiffness reflects splanchnic flow better than liver stiffness. [2] [3] [4] [5] Studies have been conducted on the tissue elasticity of intra-abdominal solid organs using 2-dimensional (2D) shear wave elastography (SWE) based on an ultrafast ultrasound (US) imaging approach. 6 Shear wave elastography relies on the generation of shear waves caused by the displacement of tissues induced by the force of a focused US beam. The propagation velocity of the shear waves correlates with the elasticity of the tissue. Unlike transient elastography, 2D SWE displays a realtime elastographic signal of the tissue parenchyma along with a grayscale image of the anatomic structure. Tissue elasticity can be measured by selecting the region of interest (ROI), and it can be measured over a larger area than in other sonoelastographic modalities. Recent studies have shown that 2D SWE has a better measurement success rate than transient elastography or point SWE in liver and spleen stiffness measurement. [7] [8] [9] [10] The measurement success rate with 2D SWE may be improved in patients with ascites and obese patients, in whom the use of transient elastography is limited by technical issues.
Measurement of spleen stiffness by sonoelastography is technically difficult, and its success rate is lower than that of liver stiffness. 1, 11, 12 Few studies have described the measurement technique and identified patient factors affecting the success of spleen stiffness measurement. We have therefore investigated the success rate of 2D SWE, and patient factors affecting its success, and we have determined the spleen stiffness value of individuals with normal spleen stiffness.
Materials and Methods

Patients and Data Collection
This retrospective study was approved by the Institutional Review Board of our hospital, and the requirement for written informed consent was waived. From October to December 2016, 313 consecutive patients who underwent liver and spleen stiffness measurements on the same day were enrolled. One of the authors recorded the underlying liver disease or the reason for the examination by reviewing electronic medical records.
Before the US examination, the heights and weights of patients were measured to calculate the body mass index (BMI).
Ultrasound Evaluation
The US examination, as well as elastography, was performed by any 1 of 3 abdominal radiologists (Y.K., S.L., and Y.S.C.) with 7, 4, and 2 years of clinical experience in liver stiffness measurement using 2D SWE as part of their regular practice, respectively. Each operator had experience with liver stiffness measurement in more than 300 patients at the outset of this study. Twodimensional SWE studies of the liver and spleen were performed with an Aixplorer US system (SuperSonic Imagine SA, Aix-en-Provence, France) equipped with a 1-6-MHz convex broadband transducer.
Patients were fasted for approximately 8 hours. Liver stiffness measurements were performed on the right lobe of the liver, through the intercostal spaces, with the patient lying in a supine position, the right arm in maximal abduction. They were asked to hold their breath after moderate exhaling, and a cine loop was obtained including a 2D SWE color map. A trapezoidal color box (3.5 3 2.5 cm in size) was positioned greater than 2 cm below the hepatic capsule and away from large vessels. Sequential frames were recalled when the elasticity in the color box was judged to reach a plateau. A round ROI (also referred to as the Q-box) was then positioned in the color box to measure the mean elasticity and its standard deviation. The stiffness value was expressed in kilopascals. The ROI was up to 2 cm in diameter, and its size was changed if necessary, according to the amount of measurable parenchyma and the locations of large vessels. Each 2D SWE value was the median of 5 sequential measurements. Invalid results were defined as interquartile range divided by median (IQR/M) of 0.3 or greater, the index of validity used for transient elastography. 13 The thickness of the abdominal wall was measured to explore the effect of the body habitus on the sonoelastographic examination, and it was done at the same plane where liver stiffness was measured. The thickness from the skin to the peritoneum was measured with an intercostal scan using a 4-15-MHz linear transducer ( Figure  F1  1 ). After the liver stiffness measurement, the size and stiffness of the spleen were measured with a 1-6-MHz convex broadband transducer. The size of the spleen was measured in the supine or right lateral decubitus position, with the spleen well visible. Spleen size was measured with the left arm at maximum abduction, and the depth of breathing was varied to increase the visibility of the spleen. After measuring the longitudinal diameter of the spleen via the intercostal scan, the perpendicular short diameter of the spleen was measured in the same plane ( Figure  F2 2A). Spleen stiffness was measured in the same way as liver stiffness. The depth of respiration was controlled individually to a level at which the elasticity signals were constant and without artifacts. Artifact-like signals underneath the splenic capsule and the major vessels of the spleen were avoided. We defined spleen stiffness values with IQR/M of less than 0.3 as valid, and a measurement was considered to be successful when a valid spleen stiffness was obtained. The measurement was considered to have failed when the spleen parenchyma did not provide a properly color-coded elastographic signals with a plateau in a Q-box, or a valid spleen stiffness value was not measured. (IQR/M 0.
3) The mean size of the ROI was recorded ( Figure 2B ).
Classification of the Patient Group: Body Habitus, Spleen Size, and Liver Stiffness The BMIs of the patients were calculated by dividing the weight by the square of the height. According to the World Health Organization criteria for Asian BMI, 14 a BMI of 25 kg/m 2 or greater is classified as obese, and a BMI of less than 25 kg/m 2 is classified as nonobese. The splenic index was calculated by multiplying the longitudinal and short diameters of the spleen. 15 According to the average size of the spleen (19.8 6 12.3 cm 2 ) as measured by Ishibashi et al, 15 a value of 44.4 cm 2 or greater (larger than the mean size by 2 SDs) was classified as splenomegaly, and a value of less than 44.4 cm 2 was classified as nonsplenomegaly.
Patients were also classified according to their measured liver stiffness value, based on the cutoff value of Jeong et al 16 Patients with liver stiffness of less than 8.6 kPa were classified as having no or mild hepatic fibrosis (METAVIR score F0 or F1). Those with liver stiffness between 8.6 and 14.0 kPa were classified as having substantial hepatic fibrosis (F2 or F3), and those with liver stiffness of 14.0 kPa or greater were classified as having liver cirrhosis (F4).
Statistical Analysis
Differences in the measurement success rates of valid spleen stiffness, mean spleen stiffness values, IQR/M, and ROI size between the patient groups were compared by the independent t test and analysis of variance. To identify the factors associated with success in obtaining valid spleen stiffness values, univariate and multivariate analyses using logistic regression were used. The associated parameters obtained in the univariate analysis were entered in a stepwise multivariate regression model, and odd ratios were obtained. The diagnostic Figure 1 . Abdominal wall thickness was measured at the same site of liver stiffness measurement using a 4-15-MHz linear transducer. The thickness was measured from the skin to the peritoneum by an intercostal scan (arrow). The liver parenchyma (asterisk) is located at the bottom of the abdominal wall.
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performances of the significant parameters obtained in the univariate analysis were assessed by an area under the receiver operating characteristic curve (AUROC) analysis, and the cutoff values maximizing the sum of sensitivity and specificity for predicting successful measurement of valid spleen stiffness values were Figure 2 . Size and stiffness measurement using SWE in 52-year-old man. A, The longitudinal diameter (a) and its perpendicular short diameter (b) were measured in the same plane with the largest splenic area. B, Ultrasound images show the color-coded mapping of SWE (top) and the corresponding B-mode image (bottom). We measured the spleen stiffness in the US window with the spleen stiffness signal generated constantly and the ROI as large as possible. SI indicates splenic index.
determined. To determine the normal spleen stiffness value, all of the patients with normal liver stiffness (<8.6 kPa) without splenomegaly were classified as the normal group, and their mean spleen stiffness value was obtained. For all analyses, P < .05 was considered statistically significant. All statistical analyses were performed with MedCalc version 9.5.1.0 statistical software (MedCalc Software, Mariakerke, Belgium).
Results
Patient Characteristics and the Success Rate of Spleen Stiffness Measurement
Of the 313 consecutive patients, 3 were excluded: 2 patients because of a splenectomy status and 1 because the spleen was invisible on the US examination. Patient information is summarized in Table  T1 1. The 22 patients in the miscellaneous group, other than the major etiology, comprised patients with congestive hepatopathy (n 5 2), sarcoidosis (n 5 1), Wilson disease (n 5 1), autoimmune or unknown origin hepatitis (n 5 14), and liver function test abnormalities (n 5 4). There were no patients with generalized infection except hepatitis or lymphoproliferative disease. Liver stiffness values were measured in 303 of the 310 patients, and valid liver stiffness values were obtained in 292 of the patients (94.2%). Spleen stiffness was measured in 181 patients, of whom 17 had IQR/M values of 0.3 or greater. Valid spleen stiffness values were obtained in 164 of the 310 patients (52.9 %). The measured patient parameters are summarized in Table  T2 2 
Comparison of Spleen Stiffness Values and Associated Parameters
The mean 6 SD of the valid spleen stiffness values for the 164 patients was 28.8 6 12.9 kPa. The mean spleen stiffness value of the nonobese patients was 29.4 6 13.7 kPa, and that of the obese patients was 28.5 6 12.5 kPa (P 5 .671). The mean spleen stiffness value of the patients with splenomegaly (35.1 6 14.4 kPa) was significantly higher than that of the patients without splenomegaly (23.7 6 8.7 kPa; P < .001). When the patients were classified by liver stiffness values, the mean spleen stiffness value increased as the liver stiffness value increased. The mean spleen stiffness values of the no-or mild-fibrosis group, the substantial fibrosis group, and the liver cirrhosis group were 20.4 6 5.7, 31.9 6 13.4, and 40.2 6 10.5 kPa, respectively, the differences being statistically significant (P < .001; Figure  F3  3 ). Valid spleen stiffness values were obtained in 65 of the 154 patients with no or mild hepatic fibrosis without splenomegaly, and their mean spleen stiffness value was 20.5 6 5.4 kPa.
The IQR/M value of the patients with splenomegaly was significantly lower (0.11 6 0.07 vs 0.16 6 0.12; P < .001), and the size of the ROI was significantly larger (15.4 6 3.7 vs 12.6 6 3.3 mm; P < .001) than in the nonsplenomegaly patients. There were no significant differences in IQR/M values and ROI sizes between the groups according to obesity and liver stiffness. Data are expressed as number of patients and mean 6 SD (range). 
Independent Predictors and Cutoff Values for Successful Measurement of Valid Spleen Stiffness Values
In a univariate analysis using logistic regression, the following parameters were associated with successful measurement of valid spleen stiffness values: BMI, abdominal wall thickness, longitudinal diameter, short diameter, splenic index, and liver stiffness. When these parameters were used in a multivariate analysis, abdominal wall thickness and longitudinal diameter of the spleen were identified as independent predictors of measurement success (Table  T3 3). A receiver operating characteristic curve analysis was performed to assess the predictive values and cutoff values of parameters for success in measuring valid spleen stiffness values. The AUROC values of abdominal wall thickness and longitudinal diameter of spleen were 0.680 and 0.761, respectively, and the cutoff values for measuring valid spleen stiffness were 17.2 mm or less and greater than 9.4 cm, respectively. The AUROC value of liver stiffness was 0.626, and the cutoff value was greater than 9.0 kPa. These findings are summarized in Table  T4 4. When the cutoff values for abdominal wall thickness and spleen longitudinal diameter were used, the spleen stiffness measurement success rate was 90.7% (88 of 97). In contrast, it was only 40.7% (61 of 150) in patients who met only 1 of the 2 cutoffs and 23.8% (15 of 63) in patients who did not meet either cutoff value.
Discussion
Shear wave elastographic measurements of liver and spleen stiffness are valid noninvasive methods for . The mean spleen stiffness value of the splenomegaly group was significantly higher than that of the nonsplenomegaly group.The mean spleen stiffness value increased as the liver stiffness value increased; the differences were statistically significant. Colecchia et al 5 suggested that spleen stiffness would be a better predictor of esophageal varices because it reflects changes in splanchnic hemodynamics more accurately than liver stiffness. There have been several studies aimed at predicting portal hypertension and esophageal varices by measuring spleen stiffness using transient elastography, but many technical limitations affected the spleen stiffness measurement. Because the spleen could not be identified in real time by transient elastography, most of the studies used spleen stiffness measurements repeated 10 times at a given location after confirming the spleen by using grayscale US, and values were accepted if the success rate was greater than 60% and the IQR/M was less than 0.3. However, when real-time 2D SWE was used to measure the spleen stiffness of noncirrhotic patients, even small changes in the depth of breathing caused the spleen to disappear from the measurable area or interposition of the lung. Therefore, some of the previous studies using transient elastography arbitrarily excluded patients with splenic parenchymal thickness of less than 4 cm or did not report failures of spleen stiffness measurement. 3, 5, 17 In previous studies using 2D SWE, the measurement success rate of spleen stiffness was generally lower than that of liver stiffness. In a study by Jansen et al, 1 liver stiffness was measured in 155 of 158 (98.1%) patients, and spleen stiffness was measured in 112 of the 158 (70.9%) patients. In a study by Grgurevic et al, 12 liver stiffness was measured in 98 of 123 (79.7 %) patients and spleen stiffness in 66 of these (53.7%) patients, whereas in a study by Elkrief et al 10 using 2D SWE, liver stiffness and spleen stiffness were both measured in 77 of 79 (97.5%) patients and had the same success rate. 10, 12 The measurement success rates of spleen stiffness in the studies by Jansen et al 1 and Elkrief et al 10 were higher than in this study because those studies included patients with advanced hepatic fibrosis and cirrhosis, who required hepatic venous pressure gradient measurements. On the other hand, in this study, we included all of the patients who were presumed to have liver disease and for whom liver stiffness measurements were requested, so that the patients were at a relatively early stage of liver disease, and we measured spleen stiffness 5 times and excluded the spleen stiffness values of patients with IQR/M of 0.3 or greater as being invalid. The other studies used the median values of 3 measurements of spleen stiffness and did not apply the validity criteria. Only Grgurevic et al 12 included a large number of noncirrhotic patients and applied a validity criterion based on the coefficient of variability, for which mean (standard deviation)/average spleen stiffness values of less than 0.3 in 5 measurements were included as valid spleen stiffness, and their measurement success rate for spleen stiffness was not substantially different from that of this study.
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Stefanescu et al 4 found that BMI and spleen size were important determinants of successful measurement of spleen stiffness using transient elastography. Balakrishnan et al 18 reported that parameters related to body habitus, including waist circumference and BMI, did not affect interobserver and intraobserver agreement on spleen stiffness measurements using point SWE; on the other hand, a larger spleen size improved interobserver and intraobserver agreement. In this study, spleen size was the most important influence on the spleen stiffness measurement success rate, as shown in previous studies. In many spleen stiffness measurements, interposition of the lung between the abdominal wall and the spleen blocked the US window. As the size of the spleen increases, the window for measuring spleen stiffness expands, and the chance of lung interposition between the spleen and abdominal wall is reduced. In measuring spleen stiffness, when the abdominal wall thickness increases, the SWE signal is not clear because of the interfering echogenic structures of the abdominal wall or the greater depth of the Q-box relative to the transducer, which is on the body surface. The normal spleen stiffness value was 20.5 6 5.4 kPa, which was higher than the mean value of Pawlus et al 19 (16.6 6 2.5 kPa) measured on healthy volunteers. The reason for the difference is that Pawlus et al 19 excluded the group with liver stiffness of greater than 6.5 kPa, whereas we excluded those with liver stiffness of greater than 8.4 kPa and included patients with mild hepatic fibrosis (METAVIR F1). In the studies by Jeong et al, 16 the reference article for liver stiffness grading for this study, and Ferraioli et al, 8 F1 fibrosis was considered to have less clinical importance and was grouped together with F0 fibrosis. Leung et al 20 showed small difference in the cutoff for spleen stiffness between patients with F1 and F2 liver fibrosis (19.4 kPa for F1 versus 19.8 kPa for F2). Pawlus et al 19 determined the spleen stiffness value of a healthy volunteer, but the normal value in this study suggested the spleen stiffness of hospitalized patients without major liver disease. In the management of portal hypertension in chronic liver disease, it would have been ideal to measure the spleen stiffness of patients with chronic liver disease who had normal portal pressure. In the absence of a reference spleen stiffness value for patients with normal portal pressure, our value could be a reference in assessing clinically acceptable spleen stiffness.
Our study had some limitations. First, it was a single-center study, and patient selection could have been biased. Most patients with alcoholic liver disease were elderly men, and many of the patients with fatty liver disease were middle-aged women. Because of this selection bias, male patients were more likely to have a higher spleen stiffness measurement success rate than female patients. Second, factors related to the measurer were not analyzed. According to Balakrishnan et al, 18 the intraclass correlation coefficient of spleen stiffness measurements was generally lower than that of liver stiffness measurements, it was good in patients with relatively large spleens. In the spleen stiffness measurements in this study, the IQR/M value was higher than that in the liver stiffness measurements, and the spleen stiffness values were more dispersed than the liver stiffness values. We suppose that the intraobserver agreement in spleen stiffness measurements was lower than in liver stiffness measurements. Third, the portal pressure and histologic characteristics of the liver parenchyma were assessed in only a few patients. Hepatic parenchymal histologic characteristics or portal pressure ought to have been measured to justify our "normal" group, but that process was difficult in practice. Therefore, we used as a normal group individuals with normal liver elasticity and spleen size, including patients with mild hepatic fibrosis, regardless of the cause of disease.
In conclusion, measurement of spleen stiffness has a low success rate and is more difficult than liver stiffness measurement because of various technical factors. Abdominal wall thickness and the longitudinal diameter of the spleen are independent factors predicting the success of spleen stiffness measurement. The spleen stiffness value of the normal group was 20.5 6 5.4 kPa. Spleen stiffness measurements that took into account these factors and made use of the reference normal spleen stiffness value could be useful for monitoring and managing chronic liver disease with portal hypertension. Further study is needed to determine the correlation between spleen stiffness and portal hypertension as a function of the cause of disease.
